|
|
|
Size
|
GlcNH2
|
Neha Gandhi <[log in to unmask]> |
Fri, 3 Mar 2017 01:12:31 -0500 |
15 lines |
Re: GlcNH2
|
David Thieker <[log in to unmask]> |
Fri, 3 Mar 2017 18:02:12 -0500 |
300 lines |
Re: GlcNH2
|
Lachele Foley <[log in to unmask]> |
Fri, 3 Mar 2017 19:43:10 -0500 |
55 lines |
Re: GlcNH2
|
Neha S. Gandhi <[log in to unmask]> |
Sun, 5 Mar 2017 23:43:11 +0000 |
41 lines |
Re: GlcNH2
|
David Thieker <[log in to unmask]> |
Mon, 6 Mar 2017 12:47:08 -0500 |
363 lines |
Re: GlcNH2
|
Lachele Foley <[log in to unmask]> |
Mon, 6 Mar 2017 19:57:17 -0500 |
102 lines |
Re: GlcNH2
|
Neha S. Gandhi <[log in to unmask]> |
Wed, 15 Mar 2017 00:14:00 +0000 |
377 lines |
Re: GlcNH2
|
Rob Woods <[log in to unmask]> |
Tue, 14 Mar 2017 20:35:14 -0400 |
371 lines |
Re: GlcNH2
|
David Thieker <[log in to unmask]> |
Wed, 15 Mar 2017 13:32:04 -0400 |
558 lines |
Extension of Glycam to lipids
|
Pallavi Banerjee <[log in to unmask]> |
Sat, 18 Mar 2017 10:25:31 -0400 |
22 lines |
Re: Extension of Glycam to lipids
|
Lachele Foley <[log in to unmask]> |
Tue, 21 Mar 2017 10:32:05 -0400 |
74 lines |
Re: Extension of Glycam to lipids
|
Pallavi Banerjee <[log in to unmask]> |
Tue, 21 Mar 2017 16:27:18 +0100 |
95 lines |
Re: GlcNH2
|
Ana Poveda <[log in to unmask]> |
Wed, 29 Mar 2017 05:47:31 -0400 |
19 lines |
Re: GlcNH2
|
David Thieker <[log in to unmask]> |
Wed, 29 Mar 2017 14:45:59 -0400 |
709 lines |
Re: GlcNH2
|
Ana Poveda <[log in to unmask]> |
Thu, 30 Mar 2017 08:07:32 +0000 |
237 lines |
glycoprotein builder
|
Hallel Freedman <[log in to unmask]> |
Thu, 30 Mar 2017 15:43:16 -0600 |
32 lines |
Re: glycoprotein builder
|
Lachele Foley <[log in to unmask]> |
Thu, 30 Mar 2017 19:45:08 -0400 |
63 lines |
Re: glycoprotein builder
|
Hallel Freedman <[log in to unmask]> |
Thu, 30 Mar 2017 17:49:56 -0600 |
5135 lines |
Re: glycoprotein builder
|
Lachele Foley <[log in to unmask]> |
Thu, 30 Mar 2017 20:37:10 -0400 |
113 lines |
Re: glycoprotein builder
|
Hallel Freedman <[log in to unmask]> |
Thu, 30 Mar 2017 18:44:17 -0600 |
128 lines |